Getinge is proud to announce the launch of the Advanta V12 32mm length balloon expandable covered stent at the Charing Cross International Conference. This is a much needed addition to the Advanta V12 product offering and will allow clinicians additional treatment options for optimal patient outcomes, a press release from the company says.
With over 200 clinical publications and close to 500,000 patients successfully treated worldwide, this latest product line extension will add to the rapidly growing body of evidence supporting the safety and efficacy of Getinge’s covered stent technology.
The Advanta V12 covered stent is a low profile, premounted balloon expandable covered stent made of a radial expandable 316L stainless steel that is completely encapsulated with a patented one-piece polytetrafluoroethylene (PTFE) covering technology. Getinge’s proprietary covering technology creates a microporous PTFE layer that completely encapsulates the stainless steel stent and allows for uniform expansion without ridges or folds in the material being formed. V12 is customisable with the ability to post dilate to meet each patient’s anatomical needs.
Getinge will also host, at Charing Cross, in partnership with Vascular International, a series of masterclass workshops in which participants will have hands-on experience using the new Advanta V12 32mm and learn the latest techniques from the experts. ‘It is extremely important to provide appropriate training and guidance to the medical community and these workshops allow not only hands-on experience on training models but also provide the participants with the opportunity to network and build relationships with medical experts” says Markus Stirner-Schilling, vice president, Marketing and Academy, Getinge, Europe, Middle East and Africa.
